Article Text

PDF
Editorial in response to the systematic review by de Vos et al: ‘Strong evidence against platelet-rich plasma injections for chronic lateral epicondylar tendinopathy: a systematic review’
  1. Taco Gosens1,
  2. Allan K Mishra2
  1. 1 Department of Orthopaedics and Traumatology, St Elisabeth Hospital Tilburg Hilvarenbeekseweg 60, Tilburg, The Netherlands
  2. 2 Department of Orthopedic Surgery, Menlo Medical Clinic, Stanford University Medical Center, Menlo Park, California, USA
  1. Correspondence to Taco Gosens, Department of Orthopaedics and Traumatology, St Elisabeth Hospital Tilburg Hilvarenbeekseweg 60, Tilburg 5022 GC, The Netherlands; t.gosens{at}elisabeth.nl

Statistics from Altmetric.com

We would like to compliment the authors on their recent efforts to construct a review article concerning the use of platelet-rich plasma (PRP) in the treatment of lateral epicondylar tendinopathy.1 As the authors of two of the studies evaluated in the paper, we would like to comment about the interpretation of our investigations and provide suggestions about the conclusions that may be drawn from the published data.

First, we would like to discuss the terminology used to describe the effect of a steroid injection in the published studies by Peerbooms et al 2 and Gosens et al 3 In these investigations, the group treated with steroids returned to baseline pain and function levels after 1 and 2 years (see figure 2 in ref 3). A steroid injection may have the negative effect implied by de Vos et al,1 but in this study we were able to show that the condition of patients did not worsen. It is therefore incorrect to use these papers2 ,3 as evidence to suggest that steroid injections are detrimental.

Second, the title of the article “Strong evidence against platelet-rich plasma injections for chronic lateral …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles